Proteomics Market Size, Share, Growth Analysis, By Instrumentation Technology(Spectroscopy (Mass Spectroscopy, NMR Spectroscopy, CD Spectroscopy), Chromatography (HPLC), By Reagent(Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents), By Service & Software(Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomics Services, Protein Purification Services), By Application(Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders), By End User(Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories), By Region - Industry Forecast 2024-2031

Global Proteomics Market size was valued at USD 25.2 billion in 2022 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031). 

The players are adopting various strategies for enhancing market penetration, some of which most significant are mergers & acquisitions, geographical expansions, and strategic partnerships. For instance, Seer, Inc. made the Broad Commercial Release of The Proteograph Product Suite and the new program called the Centers of Excellence in January of the year 2022. In detail, the Proteograph Product Suite offers comprehensive, impartial exposure to the entire proteome. The method relies on specially fabricated nanoparticles to produce a disruptive product that facilitates the large-scale and high-throughput and non-biased proteomics studies. 'Thermo Fisher Scientific Inc. (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Merck KGaA (Germany) ', 'Agilent Technologies, Inc. (US) ', 'Bruker Corporation (US) ', 'Danaher Corporation (US) ', 'GE Healthcare (US) ', 'Luminex Corporation (US) ', 'PerkinElmer Inc. (US) ', 'Waters Corporation (US) ', 'Illumina, Inc. (US) ', 'Eurofins Scientific (Luxembourg) ', 'QIAGEN Bioinformatics (Netherlands) ', 'Creative Proteomics (US) ', 'Promega Corporation (US) ', 'Sengenics (Singapore) ', 'Biomax Informatics AG (Germany) ', 'MS Bioworks LLC (US) ', 'WuXi NextCODE (China) ', 'Fios Genomics Ltd. (UK) ', 'GENEWIZ (US) ', 'Biognosys AG (Switzerland) ', 'Bioproximity (Switzerland) ', 'MRM Proteomics Inc. (Canada)'

Nano proteomics has been reported to several proteomics technologies such as phosphor proteomics/metal oxide nanoparticles, protein microarrays, and nanostructured surfaces for the separation of proteins/biomarker analytical detection. Thus, it gives birth to Nano proteomics, a science where proteomics techniques are supported by nanotechnology. This technique works in combination with other nanotechnology applications in the proteomics such as nano porous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures.

North America dominated the market in 2023 and accounts for 45% of total revenue. This is due to increased investments in structure-based drug design, growth in omics research, demand for high-quality research tools for data reproducibility and focus on the development of tailored treatments. Partnerships and collaborations among major companies in this region are also assisting in the market's expansion. Thermo Fisher Scientific Inc. and Symphogen, for example, collaborated to develop validated platform processes for the streamlined characterization and quality monitoring of complex therapeutic proteins.